After delivery and completion of breastfeeding, restarting GLP-1 therapy such as semaglutide injections may be appropriate to prevent postpartum weight regain and reduce long-term cardiometabolic disease risk
In Toxicologists Pocket Handbook , p
For premenopausal women, the shift in body composition produced by GLP-1 therapy, particularly the reduction in visceral fat, generally improves the hormonal environment rather than disrupting it
Their efficacy also extends beyond glycemic control
This becomes even more difficult when dealing with conditions that may have multiple contributing factors, as is often the case with vision problems in diabetic patients
We can help you understand the merits of your case, legal options, and if needed, fight for the compensation you deserve